Spots Global Cancer Trial Database for recurrent brain tumor
Every month we try and update this database with for recurrent brain tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| HUMC 1612: Optune NovoTTF-200A System | NCT03128047 | High Grade Glio... Ependymoma | Optune NovoTTF-... | 5 Years - 21 Years | Hackensack Meridian Health | |
| Study of Immunotoxin, MR1-1 | NCT01009866 | Supratentorial ... | MR1-1 | 18 Years - | Duke University | |
| VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM | NCT03149575 | Glioblastoma Mu... Glioblastoma Glioma GBM Brain Cancer | VAL-083, Dianhy... Physician's Cho... Physician's Cho... Physician's Cho... | 18 Years - | Kintara Therapeutics, Inc. | |
| Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients | NCT02796261 | Anaplastic Astr... Recurrent Anapl... | Eflornithine Lomustine Lomustine | 18 Years - | Orbus Therapeutics, Inc. | |
| Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors | NCT00747253 | Brain Tumor Brain Tumor, Re... Brain Neoplasm Brain Cancer Glioblastoma Mu... Recurrent Gliob... | AutoLITT system | 18 Years - | Monteris Medical | |
| A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme | NCT03025893 | Glioblastoma Mu... Glioblastoma, A... Glioblastoma Recurrent Brain... GBM | Sunitinib Lomustine | 18 Years - | Amsterdam UMC, location VUmc | |
| Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors | NCT05169944 | Brain Cancer Malignant Brain... Recurrent Brain... Progressive Mal... Brain Tumor, Pe... Brain Tumor Adu... | Magrolimab | 3 Years - | University of California, San Francisco | |
| Study of Immunotoxin, MR1-1 | NCT01009866 | Supratentorial ... | MR1-1 | 18 Years - | Duke University | |
| Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients | NCT02796261 | Anaplastic Astr... Recurrent Anapl... | Eflornithine Lomustine Lomustine | 18 Years - | Orbus Therapeutics, Inc. | |
| Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma | NCT01478178 | Glioma Glioblastoma Glioblastoma Mu... GBM Brain Cancer | VAL-083 (Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting | NCT02717962 | Glioma Glioblastoma Glioblastoma Mu... GBM Brain Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors | NCT05169944 | Brain Cancer Malignant Brain... Recurrent Brain... Progressive Mal... Brain Tumor, Pe... Brain Tumor Adu... | Magrolimab | 3 Years - | University of California, San Francisco | |
| A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme | NCT03025893 | Glioblastoma Mu... Glioblastoma, A... Glioblastoma Recurrent Brain... GBM | Sunitinib Lomustine | 18 Years - | Amsterdam UMC, location VUmc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
